Claims for Patent: 6,541,220

Summary for Patent: 6,541,220

Title:	Nucleic acid encoding PTH1R receptor
Abstract:	The present invention relates to novel parathyroid hormone (PTH) and parathyroid hormone related protein (PTHrP) receptors (PTH1R and PTH3R) isolated from zebrafish. The receptors of the present invention share homology with previously identified parathyroid hormone (PTH)/parathyroid related protein (PTHrP) receptors. Isolated nucleic acid molecules are provided encoding the zebrafish PTH1R and PTH3R receptors. PTH1R and PTH3R receptor polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of PTH1R and PTH3R receptor activity and to diagnostic and therapeutic methods.
Inventor(s):	Juppner; Harald (Cambridge, MA), Rubin; David A. (Needham, MA)
Assignee:	The General Hospital Corporation (Boston, MA)
Application Number:	09/449,632
Patent Claims:	1. An isolated nucleic acid molecule comprising a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding a parathyroid hormone (PTH)/PTH-related peptide (PfHrP) receptor (PTH1R receptor) having the complete amino acid sequence of amino acids 1 to 536 in SEQ ID NO:2; (b) a nucleotide sequence encoding the PTH1R receptor having the amino acid sequence of amino acids 2 to 536 in SEQ ID NO:2; (c) a nucleotide sequence encoding the mature PTH1R receptor having the amino acid sequence of amino acids 25 to 536 in SEQ ID NO:2; (d) a nucleotide sequence encoding the PTH1R receptor having the complete amino acid sequence encoded by the cDNA clone deposited with the ATCC as deposit PTA-916; (e) a nucleotide sequence encoding the mature PTH1R receptor having the amino acid sequence encoded by the cDNA deposited with the ATCC as deposit PTA-916; (f) a nucleotide sequence encoding the PTH1R extracellular domain, said extracellular domain having the amino acid sequence of amino acids 25 to 147 in SEQ ID NO:2; (g) a nucleotide sequence encoding the PTH1R transmembrane domain, said transmembrane domain having the amino acid sequence of amino acids 148 to 416 in SEQ ID NO:2; and (h) a nucleotide sequence complementary to any of the nucleotide sequences in (a), (b), (c), (d), (e), (f) or (g). 2. The nucleic acid molecule of claim 1 wherein said polynucleotide has the complete nucleotide sequence of the cDNA clone deposited with the ATCC as deposit PTA-916. 3. The nucleic acid molecule of claim 1 wherein said polynucleotide has the nucleotide sequence encoding the PTH1R receptor having the complete amino acid sequence encoded by the cDNA deposited with the ATCC as deposit PTA-916. 4. The nucleic acid molecule of claim 1 wherein said polynucleotide has the nucleotide sequence encoding the mature PTH1R receptor having the amino acid sequence encoded by the cDNA clone deposited with the ATCC as deposit PTA-916. 5. An isolated nucleic acid molecule comprising a polynucleotide which hybridizes under stringent hybridization conditions to a polynucleotide having a nucleotide sequence identical to a nucleotide sequence in (a), (b), (c), (d), (e), (f), (g) or (h) of claim 1; wherein said stringent hybridization conditions consist of overnight incubation at 42.degree. C. in a solution comprising: 50% formamide, 5.times.SSC (150 mM NaCl, 15 mM trisodium citrate), 50 mM sodium phosphate (pH 7.6), 5.times.Dehardt's solution, 10% dextran sulfate, and 20 g/ml denatured, sheared salmon sperm DNA, followed by washing the filters in 0.1.times.SSC at 65.degree. C.; wherein said polynucleotide which hybridizes does not have the nucleotide sequence of a human, mouse, rat or bovine PTH1R; and wherein said polynucleotide which hybridizes does not hybridize under stringent hybridization conditions to a polynucleotide having a nucleotide sequence consisting of only A residues or of only T residues. 6. An isolated nucleic acid molecule comprising a polynucleotide which encodes an epitope-bearing region of a PTH1R receptor comprising an amino acid sequence of between 7 and 30 amino acids from the amino acid sequence in (a), (b), (c), (d), (e), (f) or (g) of claim 1. 7. The isolated nucleic acid molecule of claim 1, which encodes the PTH1R receptor extracellular domain. 8. The isolated nucleic acid molecule of claim 1, which encodes the PTH1R receptor transmembrane domain. 9. A method for making a recombinant vector comprising inserting an isolated nucleic acid molecule of claim 1 into a vector. 10. A recombinant vector produced by the method of claim 9. 11. A method of making a recombinant host cell comprising introducing the recombinant vector of claim 10 into a host cell. 12. A recombinant host cell produced by the method of claim 11. 13. A recombinant method for producing a PTH1R polypeptide, comprising culturing the recombinant host cell of claim 12 under conditions such that said polypeptide is expressed and recovering said polypeptide. 14. The isolated nucleic acid molecule of claim 1, wherein said polynucleotide has a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R receptor having the complete amino acid sequence of amino acids 1 to 536 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 15. The isolated nucleic acid molecule of claim 1, wherein said polynucleotide has a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R receptor having the amino acid sequence of amino acids 2 to 536 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 16. The isolated nucleic acid molecule of claim 1, wherein said polynucleotide has a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the mature PTH1R receptor having the amino acid sequence of amino acids 25 to 536 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 17. The isolated nucleic acid molecule of claim 1, wherein said polynucleotide has a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R extracellular domain, said extracellular domain having the amino acid sequence of amino acids 25 to 147 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 18. The isolated nucleic acid molecule of claim 1, wherein said polynucleotide has a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R transmembrane domain, said transmembrane domain having the amino acid sequence of amino acids 148 to 416 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 19. The isolated nucleic acid molecule of claim 5, wherein said molecule hybridizes to a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R receptor having the complete amino acid sequence of amino acids 1 to 536 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 20. The isolated nucleic acid molecule of claim 5, wherein said molecule hybridizes to a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R receptor having the amino acid sequence of amino acids 2 to 536 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 21. The isolated nucleic acid molecule of claim 5, wherein said molecule hybridizes to a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the mature PTH1R receptor having the amino acid sequence of amino acids 25 to 536 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 22. The isolated nucleic acid molecule of claim 5, wherein said molecule hybridizes to a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R receptor having the complete amino acid sequence encoded by the cDNA clone deposited with the ATCC as deposit PTA-916; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 23. The isolated nucleic acid molecule of claim 5, wherein said molecule hybridizes to a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the mature PTH1R receptor having the amino acid sequence encoded by the cDNA deposited with the ATCC as deposit PTA-916; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 24. The isolated nucleic acid molecule of claim 5, wherein said molecule hybridizes to a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R extracellular domain, said extracellular domain having the amino acid sequence of amino acids 25 to 147 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 25. The isolated nucleic acid molecule of claim 5, wherein said molecule hybridizes to a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R transmembrane domain, said transmembrane domain having the amino acid sequence of amino acids 148 to 416 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 26. A recombinant vector comprising a nucleic acid molecule of claim 1. 27. The recombinant vector of claim 26, wherein said nucleic acid molecule comprises a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R receptor having the complete amino acid sequence of amino acids 1 to 536 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 28. The recombinant vector of claim 26, wherein said nucleic acid molecule comprises a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R receptor having the complete amino acid sequence of amino acids 2 to 536 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 29. The recombinant vector of claim 26, wherein said nucleic acid molecule comprises a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R receptor having the complete amino acid sequence of amino acids 25 to 536 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 30. The recombinant vector of claim 26, wherein said nucleic acid molecule comprises a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R receptor having the complete amino acid sequence encoded by the cDNA clone deposited with the ATCC as deposit PTA-916; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 31. The recombinant vector of claim 26, wherein said nucleic acid molecule comprises a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the mature PTH1R receptor having the amino acid sequence encoded by the cDNA deposited with the ATCC as deposit PTA-916; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 32. The recombinant vector of claim 26, wherein said nucleic acid molecule comprises a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R extracellular domain, said extracellular domain having the amino acid sequence of amino acids 25 to 147 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a). 33. The recombinant vector of claim 26, wherein said nucleic acid molecule comprises a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding the PTH1R extracellular domain, said extracellular domain having the amino acid sequence of amino acids 148 to 416 in SEQ ID NO:2; and (b) a nucleotide sequence complementary to the nucleotide sequences in (a).

Details for Patent 6,541,220

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2018-11-30